Prognostic value of psoas muscle index in metastatic renal cell carcinoma patients treated with anti-VEGF therapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorArikan, Rukiye
dc.contributor.authorDemircioglu, Ozlem
dc.contributor.authorOzguven, Salih
dc.contributor.authorDemircan, Nazim Can
dc.contributor.authorAlan, Ozkan
dc.contributor.authorTelli, Tugba Akin
dc.contributor.authorIsik, Selver
dc.contributor.authorBasoglu, Tugba
dc.contributor.authorCelebi, Abdussamed
dc.contributor.authorYasar, Alper
dc.contributor.authorSahin, Ceren Ozge
dc.contributor.authorErcelep, Ozlem
dc.contributor.authorDane, Faysal
dc.contributor.authorCimsit, Canan
dc.contributor.authorYumuk, Perran Fulden
dc.date.accessioned2025-10-16T15:12:35Z
dc.date.issued2024
dc.identifier.doi10.4103/ijc.ijc\_649\_21
dc.identifier.otherWOS:001423649000030
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5514
dc.publisherWOLTERS KLUWER MEDKNOW PUBLICATIONS
dc.sourceINDIAN JOURNAL OF CANCER
dc.subjectMetastatic RCC
dc.subjectprognosis
dc.subjectpsoas muscle index
dc.subjectsarcopenia
dc.subjectskeletal muscle index
dc.titlePrognostic value of psoas muscle index in metastatic renal cell carcinoma patients treated with anti-VEGF therapy
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS